OGEN: the cash flow

MyFinsight

For the year ending 2025-12-31, OGEN had $7,534,886 increase in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Net loss	-9,842,487
Amortization of debt discount and closing costs	771,437
Stock-based compensation expense	642,364
Stock-based compensation recapture expense	-86,617
Common stock for services rendered	126,140
Other receivables	53,082
Prepaid expenses and other current assets	1,007,286
Accounts payable and accrued expenses	203,144
Net cash used in operating activities	-9,246,387
Borrowings on short-term notes payable	2,455,911
Payments on short-term notes payable	3,328,528
Net proceeds from issuance of preferred stock and warrants	15,019,700
Net proceeds from issuance of common stock	2,634,190
Net cash provided by financing activities	16,781,273
Net increase (decrease) in cash and cash equivalents	7,534,886
Cash and cash equivalents at beginning of period	864,840
Cash and cash equivalents at end of year	8,399,726

Unit: Dollar.